Atlas Trials

Aggressive Non-Hodgkin Lymphoma

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Aggressive Non-Hodgkin Lymphoma

RecordFirmDate
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma (NCT04231877)University of Washington2020-10-27
Testing the Safety of CB-5339 in Patients With Cancer (NCT04372641)National Cancer Institute (NCI)2020-06-18
Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (NCT03458260)The Lymphoma Academic Research Organisation2018-12-26
Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma (NCT03704714)Northwestern University2018-11-20
Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas (NCT03161054)Fondazione Italiana Linfomi - ETS2017-09-12
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation (NCT03246906)Fred Hutchinson Cancer Center2017-09-11
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma (NCT03035331)Mayo Clinic2017-08-15
Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma (NCT03061188)Northwestern University2017-05-23
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency (NCT01787409)Mayo Clinic2013-03-06
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies (NCT01527045)Fred Hutchinson Cancer Center2012-09-25
Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT01251575)Fred Hutchinson Cancer Center2010-12-01
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant (NCT01231412)Fred Hutchinson Cancer Center2010-11-01
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer (NCT00789776)Fred Hutchinson Cancer Center2008-10-13
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00723099)Fred Hutchinson Cancer Center2008-06-25
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00075478)Fred Hutchinson Cancer Center2003-10-01

Track Aggressive Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.